Etanercept Therapy for Sjogren's Syndrome

NCT00001954 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

NIH

Sponsor class

Conditions

Sjogren's Syndrome

Interventions

DRUG: Etanercept

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)